4//SEC Filing
Brister Mark 4
Accession 0001214659-20-000639
CIK 0001427570other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:30 PM ET
Size
5.5 KB
Accession
0001214659-20-000639
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Restricted Stock Units
2020-01-24+110,281→ 110,281 total→ Common Stock (110,281 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001323223
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:30 PM ET
- Size
- 5.5 KB